Evidence map›Paper›PMID 38808625›Full record

ArticleAmerican journal of epidemiology2024

Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplar.

Emma Pritchard, Karina-Doris Vihta, David W Eyre, Susan Hopkins, Tim E A Peto, Philippa C Matthews, Nicole Stoesser, Ruth Studley, Emma Rourke, Ian Diamond and 3 more

Abstract read
In one paragraph

Article in American journal of epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Emma PritchardNuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.ORCID 0000-0002-0963-9260
Karina-Doris VihtaNuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.
David W EyreNIHR Health Protection Research Unit in Healthcare-Associated Infections and Antimicrobial Resistance, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, United Kingdom.
Susan HopkinsNIHR Health Protection Research Unit in Healthcare-Associated Infections and Antimicrobial Resistance, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, United Kingdom.
Tim E A PetoNuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.
Philippa C MatthewsNuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.
Nicole StoesserNuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.
Ruth StudleyOffice for National Statistics, Newport NP10 8XG, United Kingdom.
Emma RourkeOffice for National Statistics, Newport NP10 8XG, United Kingdom.
Ian DiamondOffice for National Statistics, Newport NP10 8XG, United Kingdom.
Koen B PouwelsNIHR Health Protection Research Unit in Healthcare-Associated Infections and Antimicrobial Resistance, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, United Kingdom.
Ann Sarah WalkerNuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.
Covid- Infection Survey Team

Funding

Department of Health NIHR200915Department of Health on behalf of the Northern Ireland GovernmentHuo Family Foundation MC_UU_12023/22Medical Research Council MC_UU_12023/22National Institute for Health Research NIHR200915Robertson FellowshipUK Department of Health and Social CareWellcome TrustWellcome Trust 110110/Z/15/Z
6 · The paper itself

Abstract

Detecting and quantifying changes in the growth rates of infectious diseases is vital to informing public health strategy and can inform policymakers' rationale for implementing or continuing interventions aimed at reducing their impact. Substantial changes in SARS-CoV-2 prevalence with the emergence of variants have provided an opportunity to investigate different methods for doing this. We collected polymerase chain reaction (PCR) results from all participants in the United Kingdom's COVID-19 Infection Survey between August 1, 2020, and June 30, 2022. Change points for growth rates were identified using iterative sequential regression (ISR) and second derivatives of generalized additive models (GAMs). Consistency between methods and timeliness of detection were compared. Of 8 799 079 study visits, 147 278 (1.7%) were PCR-positive. Change points associated with the emergence of major variants were estimated to occur a median of 4 days earlier (IQR, 0-8) when using GAMs versus ISR. When estimating recent change points using successive data periods, 4 change points (4/96) identified by GAMs were not found when adding later data or by ISR. Change points were detected 3-5 weeks after they occurred under both methods but could be detected earlier within specific subgroups. Change points in growth rates of SARS-CoV-2 can be detected in near real time using ISR and second derivatives of GAMs. To increase certainty about changes in epidemic trajectories, both methods could be used in parallel.

Indexed as

COVID-19SARS-CoV-2AdultAgedFemaleHumansMaleMiddle AgedPopulation SurveillancePrevalenceUnited Kingdomchange-point detectioncommunity surveillancereal-time monitoringSARS-CoV-2 infection

Identifiers

PMID38808625
PMCPMC7616874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.